ADT Inc. (ADT) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.16B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | 1.29B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $5.16B | (m) | $1.29B | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $5.14B | (m) | $1.32B | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $5.13B | (m) | $1.31B | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $5.11B | (m) | $1.28B | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $5.06B | (m) | $1.29B | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $4.98B | (m) | $1.24B | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $4.90B | (m) | $1.21B | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $5.14B | (m) | $541.34M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $5.08B | (m) | $521.55M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $4.91B | (m) | $731.33M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $4.98B | (m) | $510.29M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $6.30B | (m) | $480.42M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $6.46B | (m) | $338.47M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $6.46B | (m) | $526.99M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $6.40B | (m) | $560.25M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $6.13B | (m) | $364.34M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $5.84B | (m) | $320.09M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $5.55B | (m) | $107.64M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $5.31B | (m) | $15.28M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | $21.52M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $61.31M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | $113.62M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $40.64M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | $88.06M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | $-26.06M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | $16.65M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | $196.44M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | $143.03M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | $316.11M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | $296.89M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | $277.84M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | (m) | $282.44M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | $-229.31M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arlo Technologies, Inc. (ARLO) | United States | $1.402B | 44.06 |
| Allegion plc (ALLE) | Ireland | $12.967B | 18.14 |